𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined quantitative dynamic contrast-enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer

✍ Scribed by Ferdinand A. van Dorsten; Marinette van der Graaf; Marc R.W. Engelbrecht; Geert J.L.H. van Leenders; Albert Verhofstad; Mark Rijpkema; Jean J.M.C.H. de la Rosette; Jelle O. Barentsz; Arend Heerschap


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
418 KB
Volume
20
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis


Purpose:

To differentiate prostate carcinoma from healthy peripheral zone and central gland using quantitative dynamic contrast-enhanced (dce) magnetic resonance (mr) imaging and two-dimensional (1)h mr spectroscopic imaging (mrsi) combined into one clinical protocol.

Materials and methods:

Twenty-three prostate cancer patients were studied with a combined dce-mri and mrsi protocol. cancer regions were localized by histopathology of whole mount sections after radical prostatectomy. pharmacokinetic modeling parameters, k(trans) and k(ep), as well as the relative levels of the prostate metabolites citrate, choline, and creatine, were determined in cancer, healthy peripheral zone (pz), and in central gland (cg).

Results:

K(trans) and k(ep) were higher (p < 0.05) in cancer and in cg than in normal pz. the (choline + creatine)/citrate ratio was elevated in cancer compared to the pz and cg (p < 0.05). while a (choline + creatine)/citrate ratio above 0.68 was found to be a reliable indicator of cancer, elevated k(trans) was only a reliable cancer indicator in the diagnosis of individual patients. k(trans) and (choline + creatine)/citrate ratios in cancer were poorly correlated (pearson r(2) = 0.07), and thus microvascular and metabolic abnormalities may have complementary value in cancer diagnosis.

Conclusion:

The combination of high-resolution spatio-vascular information from dynamic mri and metabolic information from mrsi has excellent potential for improved localization and characterization of prostate cancer in a clinical setting. j. magn. reson. imaging 2004;20:279-287.


📜 SIMILAR VOLUMES


Combined dynamic contrast enhanced breas
✍ Michael A. Jacobs; Peter B. Barker; Pedram Argani; Ronald Ouwerkerk; Zaver M. Bh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB

## Abstract ## Purpose To investigate the feasibility of combined dynamic contrast enhanced (DCE) and magnetic resonance spectroscopy (MRS) in evaluating breast lesions. ## Methods Nine patients with positive mammograms scheduled for either biopsy or mastectomy were examined on a 1.5‐T MR scanne

Enhanced mass on contrast-enhanced breas
✍ Hidetake Yabuuchi; Yoshio Matsuo; Takashi Okafuji; Takeshi Kamitani; Hiroyasu So 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

## Abstract ## Purpose To evaluate the diagnostic accuracy of a combination of dynamic contrast‐enhanced MR imaging (DCE‐MRI) and diffusion‐weighted MR imaging (DWI) in characterization of enhanced mass on breast MR imaging and to find the strongest discriminators between carcinoma and benignancy.

Dynamic contrast-enhanced MR imaging for
✍ Michael Horn; Markus Oechsner; Marianna Gardarsdottir; Herbert Köstler; Markus F 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

## Abstract ## Purpose To characterize rounded atelectasis (RA) with dynamic contrast‐enhanced MRI in the differential diagnosis of solitary peripheral pulmonary neoplasm. ## Materials and Methods Twenty‐four patients with diagnostically equivocal peripheral pulmonary nodules were examined with

Reproducibility of 3D 1H MR spectroscopi
✍ Miriam W. Lagemaat; Christian M. Zechmann; Jurgen J. Fütterer; Elisabeth Weiland 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

## Abstract ## Purpose: To determine the reproducibility of 3D proton magnetic resonance spectroscopic imaging (^1^H‐MRSI) of the human prostate in a multicenter setting at 1.5T. ## Materials and Methods: Fourteen subjects were measured twice with 3D point‐resolved spectroscopy (PRESS) ^1^H‐MRSI